Background: Postoperative reflux (POR) is common following surgical treatment of colic and is associated with increased mortality, prolonged hospitalisation and higher treatment costs. Objectives: To evaluate the clinical efficacy of intravenous lidocaine administered for 48–72 hours postoperatively in horses following surgical treatment of small intestinal obstruction. Study design: Randomised, placebo-controlled, double-blind multicentre superiority clinical trial. Methods: Eligible horses undergoing emergency laparotomy to treat acute colic caused by small intestinal obstruction at participating hospitals (UK n=7, Belgium n=1) were randomised 1:1 to receive a continuous intravenous infusion of lidocaine or saline placebo for 48 (minimum) to 72 (maximum) hours following surgery and anaesthetic recovery. The primary outcome was the proportion of horses that developed POR during the infusion (≥2 L net reflux on ≥2 occasions). Secondary outcomes included other measures of gastrointestinal function and systemic patient status, surgical morbidities, short- and long-term postoperative mortality, and occurrence of adverse events. Results: A significantly greater proportion of horses developed POR in the lidocaine (55/137, 40.1%) compared to the placebo group (41/140, 29.3%), (adjusted relative risk 1.51, 95% confidence interval 1.10–2.08; p=0.011). Total reflux volume was greater in the lidocaine group (median 2 L versus 0 L; p=0.047). No statistically significant between-group differences were observed for all other secondary outcomes. Infusion-related serious adverse events occurred in 4 horses (1.4%), all in the lidocaine group; non-serious adverse events occurred in 23 horses (8.3%). Main limitations: Serum lidocaine concentrations and hepatic function were not measured. Intraoperative lidocaine administration was not randomised. Conclusions: In horses undergoing emergency laparotomy for small intestinal obstruction, the proportion of horses that developed POR was higher in horses receiving postoperative lidocaine infusion for 48–72 hours compared with placebo. These findings do not support routine postoperative lidocaine use to accelerate gastrointestinal recovery or improve clinical outcomes in this surgical population.